Tetragon Financial Management LP 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 4:10 pm Sale |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
Tetragon Financial Management LP | 8,000,000 4.600% |
-1,461,883 (-15.45%) |
Filing |
| 2023-03-20 09:13 am Purchase |
2023-03-09 | 13G | Autolus Therapeutics plc AUTL |
Tetragon Financial Management LP | 9,461,883 5.500% |
9,461,883 (New Position) |
Filing |